» Download Public Reports
About 100 reports
- Company report
- May 2013
- 12 pages
... Nesses to obtain a sufficient return on in- vestment. When you look at the facts, more and more money now has to be invested before a drug hits the market. According to na t u r e re v i e w s dr u g ...
May 2013
... Fda gives 'breakthrough' designa- tion to merck skin-cancer drug by peter loftus an experimental merck & co. (Mrk) skin-cancer drug was designated as a "breakthrough therapy" by the u ...
March 2013
... Wido 2013 market penetration of drugs under patent turnover per patent drug (mill. ) Scripts per patent drug (thousands) per calendar year, starting from year of introduction into market source: avr ...
December 2012
... Therapeutics plc (aim: agy), the fully integrated speciality pharmaceutical company specialising in allergy vaccines, announces the interim results for the six months ended 31 december 2012. Highlights ...
November 2012
... A drug company engaged in 5-ala businesses under the umbrella of the group, and jointly promote the development of medicine so as to broaden the adaptation of interoperative diagnostic drugs ...
September 2012
... Are similar to those of drug addiction 09/09/2012 biochemical mechanisms anabolic steroids affect muscle mass by: 1. Increasing the production of proteins 2. Reduce recovery time by blocking the effects ...
September 2012
... In cannabis / marijuana. They bind to the same cannabinoid receptors in the brain as thc. However, many of the synthetic cannabinoids are much more potent than thc. Usually the synthetic cannabinoids ...
August 2012
... Encephalitis tuberculosis typhoid fever varicella (chickenpox) yellow fever 16/08/2012 evolution of medical innovation from edward jenner to gavi Global vaccine market 2009 was us$24 ...
» Purchase Premium Reports
(From $ 125 - $ 4 995)
About 100 reports
- $ 4 995
- Industry report
- May 2013
- by Global Data
PharmaPoint: Hepatitis C Virus - Germany Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, ?PharmaPoint: Hepatitis C Virus - Germany Drug Forecast and Market ...
May 2013
$ 5 174
This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in the top 10 global countries. The studies provide essential market information ...
April 2013
$ 1 088
BMI View: Despite the threat of austerity measures and the government's focus on cost-containment within the pharmaceuticals and healthcare segment, as well as the impact of generic competition as a result ...
May 2013
$ 652
This market research report offers a perspective on the actual market situation, trends and future outlook for vaccines in Germany. The study provides essential market information for decision-makers including: ...
April 2013
$ 250
Summary CureVac GmbH (Curevac) is a biotechnology company, based in Germany. The company designs, develops and produces therapeutically active messenger RNA (mRNA) molecules. It focuses on the therapeutic ...
April 2013
$ 125
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...